Biotechnology startups and businesses are in danger of new technologies, discoveries, patents and competitors and usually beginners ask: what percentage of biotechnological companies fail?
It can take a decade to get a new drug from the test tube to the pharmacy shelf. What’s more, there is an overwhelming likelihood of failure, as 90% of all prospective new drugs fail to reach approval. 1 Still, for those that succeed, the rewards can be tremendous, and “daily doubles” are not unheard of.